StarZero All shows Try the podcast clipper →

OpenEvidence

also referred to as: open evidence

9 statements across 4 episodes · 8 bullish · 0 bearish · 4 people on the record · first statement Oct 27, 2025 by David Cahn · said 41 times in 9 episodes since 2025 · across every show →

Mentions by year

brought up most by Harry Stebbings (19), Jason Lemkin (13), Alex Rampell (2), Rory O'Driscoll (1), David Cahn (1), Anish Acharya (1)

tap a year for its mentions
0015330620252026episodesmentions
03620252026episodes it came up in
002.535620252026episodesmentions per episode
2026 29 mentions in 6 episodes 5 per episode
2025 12 mentions in 3 episodes 4 per episode

every mention, scene by scene, with the transcript →

Everything said about OpenEvidence, oldest first

Oct 27, 2025 bullish
Assertion Open · timeframe Oct 2027
Cahn: Harvey, Open Evidence, Clay, and Juicebox are reaching $100M ARR rapidly
“Companies that are on that trajectory or have crossed that trajectory are companies like Harvey and Open Evidence and I think, and Clay and Juicebox.”
David Cahn Oct 27, 2025 ▶ 40:44 Sequoia Partner, David Cahn on Who Wins in AI, Defence & The New $0–$100M Playbook · 20VC with Harry Stebbings
Nov 6, 2025 positive
Assertion Partly supported
Stebbings: Open Evidence Reached 300,000 Doctors 10x Faster Than Doximity
“Open evidence grew to 300,000 doctors in one year, which is one 10th of the amount of time it took Doximity.”
Harry Stebbings Nov 6, 2025 ▶ 1:05:37 Is a $4.5BN Exit Enough in VC? & Harvey Raises $150M & Why Google is a Buy and Amazon is a Sell · 20VC with Harry Stebbings
Dec 22, 2025 bullish
Assertion Partly supported
Rory O'Driscoll: Open Evidence reached 500,000 U.S. doctors in one year
“And they went from nothing to 500,000 doctors out of about a million in the U.S. In the space of one year.”
Rory O'Driscoll Dec 22, 2025 ▶ 22:47 Predictions for 2026: Top Buy & Biggest Short | Why Salesforce Could Win & NVIDIA’s Challenges · 20VC with Harry Stebbings
Jan 29, 2026 positive
Assertion Supported
O'Driscoll: Open Evidence 10xed revenue and valuation over the past year
“They tenxed revenue this year, and they tenxed their valuation plus or minus, and so the revenue multiple is the same, right?”
Rory O'Driscoll Jan 29, 2026 ▶ 44:59 Anthropic Inference Costs Skyrocket |TikTok Deal Closes |The IPO Market:Wealthfront & EquipmentShare · 20VC with Harry Stebbings
Jan 29, 2026 bullish
Insight
Lemkin: AI inference costs are replacing traditional sales and marketing budgets
“The other advantage that the new entrants have is that if you have the best agent and you have the kind of market demand we see, right, then you're for you, your inference costs are a marketing cost. The established players don't have that luxury. They're alre…”
Jason Lemkin Jan 29, 2026 ▶ 31:12 Anthropic Inference Costs Skyrocket |TikTok Deal Closes |The IPO Market:Wealthfront & EquipmentShare · 20VC with Harry Stebbings
Jan 29, 2026 bullish
Assertion Supported
O'Driscoll: Open Evidence has reached $150M in revenue
“And they've escalated to, I believe, a hundred and fifty million in revenue, right?”
Rory O'Driscoll Jan 29, 2026 ▶ 40:29 Anthropic Inference Costs Skyrocket |TikTok Deal Closes |The IPO Market:Wealthfront & EquipmentShare · 20VC with Harry Stebbings
Jan 29, 2026 positive
Assertion Supported
Stebbings: Open Evidence raised at $12B valuation led by Thrive and DST
“Open Evidence raises at twelve billion dollars, labbed by Thriving DST. It's a 12 x valuation step up to where they raised at a billion dollars from Sikora at the start of the year.”
Harry Stebbings Jan 29, 2026 ▶ 39:08 Anthropic Inference Costs Skyrocket |TikTok Deal Closes |The IPO Market:Wealthfront & EquipmentShare · 20VC with Harry Stebbings
Jan 29, 2026 neutral
Prediction Not checkable as stated
O'Driscoll: Open Evidence must expand TAM significantly to 3x its $12B valuation
“So to get to get three X from twelve billion, you probably have to do some significant time expansion.”
Rory O'Driscoll Jan 29, 2026 ▶ 42:42 Anthropic Inference Costs Skyrocket |TikTok Deal Closes |The IPO Market:Wealthfront & EquipmentShare · 20VC with Harry Stebbings
Jan 29, 2026 bullish
Prediction Open · timeframe Dec 2027
Lemkin: Open Evidence will raise at $30B-$40B valuation next year
“Open Evidence will probably do a round at 30 or 40 next year. I'm actually going to suggest that Thrive is very smart. And they've probably done the math and this is the right insertion point for them. And they believe in it. And someone else is going to do it…”
Jason Lemkin Jan 29, 2026 ▶ 43:44 Anthropic Inference Costs Skyrocket |TikTok Deal Closes |The IPO Market:Wealthfront & EquipmentShare · 20VC with Harry Stebbings
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,200 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more